Clinical Trials Browser

Carcinoma, Ovarian Epithelial × apatinib × Clear all

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Phase 3 Not yet recruiting

Carcinoma, Ovarian Epithelial

NCT03587129 2020-08-05

Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms